Free Trial

Agilon Health (NYSE:AGL) Stock Price Down 5.2% Following Analyst Downgrade

Agilon Health logo with Medical background

Shares of Agilon Health, Inc. (NYSE:AGL - Get Free Report) dropped 5.2% during trading on Wednesday after Evercore ISI lowered their price target on the stock from $5.00 to $3.00. Evercore ISI currently has an in-line rating on the stock. Agilon Health traded as low as $2.26 and last traded at $2.27. Approximately 412,174 shares were traded during mid-day trading, a decline of 92% from the average daily volume of 5,292,059 shares. The stock had previously closed at $2.39.

Other equities research analysts have also recently issued reports about the stock. Wells Fargo & Company decreased their target price on shares of Agilon Health from $6.00 to $5.00 and set an "overweight" rating on the stock in a research report on Tuesday, May 13th. Barclays upped their price objective on Agilon Health from $2.00 to $3.00 and gave the stock an "underweight" rating in a report on Thursday, May 8th. Citigroup upgraded Agilon Health from a "neutral" rating to a "buy" rating and upped their price objective for the stock from $3.25 to $5.00 in a report on Friday, April 25th. Sanford C. Bernstein upgraded Agilon Health from a "market perform" rating to an "outperform" rating and upped their price objective for the stock from $3.30 to $8.50 in a report on Tuesday, April 8th. Finally, Needham & Company LLC reaffirmed a "hold" rating on shares of Agilon Health in a research note on Friday, March 21st. Two research analysts have rated the stock with a sell rating, eleven have assigned a hold rating and five have assigned a buy rating to the stock. According to MarketBeat, the stock has a consensus rating of "Hold" and a consensus target price of $4.71.

Get Our Latest Research Report on AGL

Institutional Trading of Agilon Health

Large investors have recently bought and sold shares of the company. SG Americas Securities LLC grew its position in Agilon Health by 1,271.3% in the first quarter. SG Americas Securities LLC now owns 144,189 shares of the company's stock valued at $624,000 after acquiring an additional 133,674 shares in the last quarter. Wealth Enhancement Advisory Services LLC lifted its holdings in Agilon Health by 21.8% in the 1st quarter. Wealth Enhancement Advisory Services LLC now owns 99,697 shares of the company's stock worth $432,000 after buying an additional 17,866 shares in the last quarter. Price T Rowe Associates Inc. MD lifted its holdings in Agilon Health by 41.0% in the 4th quarter. Price T Rowe Associates Inc. MD now owns 338,529 shares of the company's stock worth $644,000 after buying an additional 98,377 shares in the last quarter. Cerity Partners LLC acquired a new position in Agilon Health in the 4th quarter worth $34,000. Finally, MetLife Investment Management LLC lifted its holdings in Agilon Health by 4.0% in the 4th quarter. MetLife Investment Management LLC now owns 174,551 shares of the company's stock worth $332,000 after buying an additional 6,762 shares in the last quarter.

Agilon Health Stock Performance

The stock has a market cap of $933.46 million, a price-to-earnings ratio of -3.82 and a beta of 0.16. The business's fifty day simple moving average is $2.48 and its 200 day simple moving average is $3.23.

Agilon Health (NYSE:AGL - Get Free Report) last issued its quarterly earnings data on Tuesday, May 6th. The company reported $0.03 earnings per share for the quarter, beating analysts' consensus estimates of ($0.01) by $0.04. Agilon Health had a negative return on equity of 45.47% and a negative net margin of 4.04%. The firm had revenue of $1.53 billion during the quarter, compared to analyst estimates of $1.50 billion. During the same quarter last year, the firm earned ($0.02) EPS. Agilon Health's quarterly revenue was down 4.5% on a year-over-year basis. As a group, analysts forecast that Agilon Health, Inc. will post -0.59 EPS for the current fiscal year.

Agilon Health Company Profile

(Get Free Report)

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.

Further Reading

Should You Invest $1,000 in Agilon Health Right Now?

Before you consider Agilon Health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Agilon Health wasn't on the list.

While Agilon Health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Don’t Miss These Top 3 Defense Stocks Set To Gain
Triple-Digit Gains: These 4 Nuclear Stocks Have Even More Upside Ahead
3 Made in America Stocks Under $20 You Need to See!

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines